Structure of mouse 7S NGF: A complex of nerve growth factor with four binding proteins

Structure

Volumn 5, Issue 10, 1997, Pages 1275-1285

  Bax, Ben ^a   Blundell, Tom L ^a,c   Murray Rust, Judith ^a,b   McDonald, Neil Q ^a,b  

^a UNIVERSITY OF LONDON   (United Kingdom)

^b IMPERIAL CANCER RESEARCH FUND   (United Kingdom)

^c UNIVERSITY OF CAMBRIDGE   (United Kingdom)

Author keywords

Kallikrein; Nerve growth factor (NGF); Protein protein interactions; Serine proteinase

Indexed keywords

EID: 0031572822     PISSN: 09692126     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0969-2126(97)00280-3     Document Type: Article

References (58)

1. Angeletti, R.H. & Bradshaw, R.A. (1971). Nerve growth factor from mouse submaxillary gland: amino acid sequence. Proc. Natl. Acad. Sci. USA 68, 2417-2420.
2. Barde, Y.-A. (1994). Neurotrophic factors: an evolutionary perspective. J. Neurobiol. 25, 1329-1333.
3. Kaplan, D.R. & Miller, F.D. (1997). Signal transduction by the neurotrophin receptors. Curr. Opin. Cell Biol. 9, 213-221.
4. McDonald, N.Q., Lapatto, R., Murray-Rust, J., Gunning, J., Wlodawer, A. & Blundell, T.L. (1991). New protein fold revealed by a 2.3 Å resolution structure of nerve growth factor. Nature 354, 411-414.
5. Murray-Rust, J., et al., & Bradshaw, R.A. (1993). Topological similarities in TGF-• 2, PDGF-BB and NGF define a superfamily of polypeptide growth factors. Structure 1, 153-159.
6. Bradshaw, R.A., Murray-Rust, J., Ibáñez, C.F., McDonald, N.Q., Lapatto, R. & Blundell, T.L. (1994). Nerve growth factor. Structure/function relationships. Protein Sci. 3, 1901-1913.
7. Ibáñez, C.F. (1995). Neurotrophic factors: from structure function studies to designing effective therapeutics. Trends Biotech. 13, 217-227
8. Levi-Montalcini, R. (1987). The nerve growth factor 35 years later. Science 237, 1154-1162.
9. Varon, S., Nomura, J. & Shooter, E.M. (1967). Subunit structure of a high-molecular-weight form of the nerve growth factor from mouse submaxillary gland. Proc. Natl. Acad. Sci. USA 57, 1782-1789.
10. Varon, S., Nomura, J. & Shooter, E.M. (1968). Reversible dissociation of the mouse nerve growth factor protein into different subunits. Biochemistry 7, 1296-1303.
11. Silverman, R.E. & Bradshaw, R.A. (1982). Nerve growth factor: subunit interactions in the mouse submaxillary gland 7S complex. J. Neurosci. Res. 8, 127-136.
12. Pattison, S.E. & Dunn, M.F. (1975). On the relationship of zinc ion to the structure and function of the 7S nerve growth factor protein. Biochemistry 14, 2733-2739.
13. Bothwell, M.A. & Shooter, E.M. (1978). Thermodynamics of interaction of the subunits of 7S nerve growth factor - the mechanism of activation of the esteropeptidase activity by chelators. J. Biol. Chem. 253, 8458-8464.
14. Palmer, T.E. & Neet, K.E. (1980). Subunit interactions in 7S nerve growth factor. •-Esterase activity as a probe of the dissociation of the 7S oligomer by salt and EDTA. J. Biol. Chem. 255, 5170-5176.
15. Palmer, T.E. & Neet, K.E. (1980). Subunit interactions in 7S nerve growth factor: Sedimentation analysis of the dissociation of the 7S oligomer promoted by salt and ethylenediaminetetracetate. Arch. Biochem. Biophys. 205, 412-421.
16. Rao, A.G. & Neet, K.E. (1984). Subunit interactions of 7S nerve growth factor: •-Esterase activity, rates and conformational changes during reassociation. J. Biol. Chem., 259, 73-79.
17. Harris-Warwick, R.M., Bothwell, M.A. & Shooter, E.M. (1980). Subunit interactions inhibit the binding of • nerve growth factor to receptors on embryonic chick sensory neurons. J. Biol. Chem. 255, 11284-11289.
18. Stach, R.W. & Shooter, E.M. (1980). Cross-linked 7S nerve growth factor is biologically inactive. J. Neurochem. 34, 1499-1505
19. Woodruff, N.R. & Neet, K.E. (1986). Inhibition of • nerve growth factor binding to PC12 cells by • nerve growth factor and • nerve growth factor. Biochemistry 25, 7967-7974.
20. Thomas, K.A., Baglan, N.C. & Bradshaw, R.A. (1981). The amino acid sequence of the •-subunit of mouse submaxillary gland 7S nerve growth factor. J. Biol. Chem. 256, 9156-9166.
21. Ullrich, A., Gray, A., Wood, W.I., Hayflick, J. & Seeburg, P.H. (1984). Isolation of a cDNA clone coding for the •-subunit of mouse nerve growth factor using a high-stringency selection procedure. DNA 3, 387-392.
22. Isackson, P.J., Ullrich, A. & Bradshaw, R.A. (1984). Mouse 7S nerve growth factor: complete sequence of a cDNA coding for the •-subunit precursor and its relationship to serine proteases. Biochemistry 23, 5997-6002
23. Edwards, R.H., Selby, M.J., Garcia, P.O. & Rutter, R.J. (1988). Processing of the native nerve growth factor precursor to form biologically active nerve growth factor. J. Biol. Chem. 263, 6810-6815.
24. Jongstra-Bilen, J., Coblentz, L. & Shooter, E.M. (1989). The in vitro processing of the NGF precursors by the •-subunit of the 7S NGF complex. Brain Res. Mol. Brain Res. 5, 159-169.
25. Isackson, P.J. & Bradshaw, R.A. (1984). The •-subunit of mouse 7S nerve growth factor is an inactive serine protease. J. Biol. Chem. 259, 5380-5383.
26. Ronne, H., Anundi, H., Rask, L. & Peterson, P.A. (1984). 7S nerve growth factor • and • subunits are closely related subunits. Biochemistry 23, 1229-1234.
27. Bode, W., Chen, Z., Bartels, K., Kutzbach, C., Schmidt-Kastner, G. & Bartunik, H. (1983). Refined 2 Å X-ray crystal structure of porcine pancreatic kallikrein A, a specific trypsin-like serine protease. J. Mol. Biol. 164, 237-282.
28. Chen, Z. & Bode, W. (1983). Refined 2.5 Å X-ray crystal structure of the complex formed by porcine kallikrein A and the bovine pancreatic trypsin inhibitor. J. Mol. Biol. 164, 283-311.
29. Fujinaga, M. & James, M.N.G. (1987). Rat submaxillary gland serine protease tonin: structure and solution refinement at 1.8 Å resolution. J. Mol. Biol. 195, 373-396.
30. Bax, B., Blaber, M., Ferguson, G., Sternberg, M.J.E. & Walls, P.H. (1993). Prediction of the three-dimensional structures of the nerve growth factor and epidermal growth factor binding proteins (kallikreins) and an hypothetical structure of the high molecular weight complex of epidermal growth factor with its binding protein. Protein Sci. 2, 1229-1241.
31. McDonald, N.Q. & Blundell, T.L (1991). Crystallization and characterization of the high molecular weight form of nerve growth factor (7S NGF). J. Mol. Biol. 219, 595-601.
32. Kleywegt, G.J. & Jones, T.A. (1994). Halloween ... masks and bones. In From First map to Final Model. (Bailey, S., Hubbard, R., & Waller, D., eds), pp. 59-65, SERC Daresbury Laboratory, Daresbury, UK.
33. Brünger, A.T. (1992). X-PLOR Version 3.1: A System for X-ray Crystallography and NMR. Yale University Press, New Haven & London.
34. Holland, D.R., Cousens, L.S., Meng, W. & Matthews, B.W. (1994). Nerve growth factor in different crystal forms displays structural flexibility and reveals zinc binding sites. J. Mol. Biol. 239, 385-400.
35. Mobley, W.C., Schenker, A. & Shooter, E.M. (1976). Characterization and isolation of proteolytically modified nerve growth factor. Biochemistry 15, 5543-5551.
36. Thomas, K.A., Silverman, R.E., Jeng, I., Baglan, N.C. & Bradshaw, R.A. (1981). Electrophoretic heterogeneity and polypeptide chain structure of the •-subunit of mouse submaxillary gland 7S nerve growth factor. J. Biol. Chem. 256, 9147-9155.
37. Burton, L.E. & Shooter, E.M. (1981). The molecular basis of the heterogeneity of the • subunit of 7S nerve growth factor. J. Biol. Chem. 256, 11011-11017.
38. Walter, J., Steigemann, W., Singh, T.P., Bartunik, H., Bode, W. & Huber, R. (1982). On the disordered activation domain in trypsinogen: chemical labelling and low-temperature crystallography. Acta Cryst. B 38, 1462-1472.
39. James, M.N.G., Sielecki, A.R., Brayer, G.D. & Delbaerre, L.T.J. (1980). Structures of product and inhibitor complexes of Streptomyces griseus protease A at 1.8 Å resolution. J. Mol. Biol. 144, 43-88.
40. Blaber, M., Isackson, P.J., Marsters, J.C. Jr., Burnier, J.P. & Bradshaw, R.A. (1989). Substrate specificities of growth factor associated glandular kallikreins of the mouse submandibular gland. Biochemistry 28, 7813-7819.
41. Moore, J.B., Mobley, W.C. & Shooter, E.M. (1974). Proteolytic modification of the • nerve growth factor protein. Biochemistry 13, 833-840.
42. Mittl, P.R.E., et al., & Grütter, G.G. (1997). A new structural class of serine protease inhibitors revealed by the structure of the hirustatin-kallikrein complex. Structure 5, 253-264.
43. Ibáñez, C.F., Ebendal, T., Barbany, G., Murray-Rust, J., Blundell, T.L. & Persson, H. (1992). Disruption of the low affinity receptor-binding site in NGF allows neuronal survival and differentiation by binding to the trk gene product. Cell 69, 329-341.
44. Ibáñez, C.F., Ilag, L.L., Murray-Rust, J., & Persson, H. (1993). Chimeric molecules with multiple neurotrophic activities reveal structural elements determining the specificities of NGF and BDNF. EMBO J. 10, 2105-2110.
45. Blaber, M., Isackson, P.J., Holden, H.M. & Bradshaw, R.A. (1993). Synthetic chimeras of mouse growth factor associated glandular kallikreins. II. Growth factor binding properties. Protein Sci. 2, 1220-1228
46. Casaccia-Bonnefil, P., Carter, B.D., Dobrowsky, R.T. & Chao, M.V. (1996). Death of oligodendrocytes mediated by the interaction of nerve growth factor with its receptor p75. Nature 383, 716-719.
47. Leslie, A.G.W., Brick, P. & Wonacott, A.T. (1986). An improved package for the measurement of oscillation photographs. Daresbury Laboratory Information Quarterly for Protein Crystallography, Vol 18. pp. 33-39, SERC Daresbury Laboratory, Warrington, UK.
48. CCP4 (1994). The CCP4 Suite: programs for protein crystallography. Acta Cryst. D 50, 760-763.
49. Navaza, J (1994). AMoRe: an automated package for molecular replacement. Acta Cryst. A 50, 157-163
50. Navaza, J (1987). On the fast rotation function. Acta Cryst. A 43, 645-653
51. Tickle, I. (1985). Review of space group general translation functions that make use of known structure information and can be expanded as fourier series. In Molecular Replacement. (Machin, P.A., ed.), pp. 22-26, SERC Daresbury Laboratory, Warrington, UK.
52. Driessen, H.P.C., Haneef, M.I.J., Harris, G.W., Howlin, B., Khan, G. & Moss, D.S. (1989). RESTRAIN: restrained structure-factor least-squares refinement program for macromolecular refinement. J. Appl. Cryst. 22, 510-516.
53. Jones, T.A., Zou, J-Y., Cowan, S.W. & Kjeldgaard, M. (1991). Improved methods for building protein models in electron density maps and the location of errors in these models. Acta Cryst A 47, 110-119.
54. Laskowski, R.A., MacArthur, M.W., Moss, D.S. & Thornton, J.M. (1993). PROCHECK: a program to check stereochemical quality of protein structures. J. Appl. Cryst. 26, 283-291.
55. Kleywegt, G.J. & Jones, T.A. (1995). Where freedom is given liberties are taken. Structure 3, 535-540.
56. Evans, S.V. (1993). SETOR: hardware lighted three-dimensional solid model representations of macromolecules. J. Mol. Graphics. 11, 134-138.
57. Nichols, A., Sharp, K.A. & Honig, B. (1991). Protein folding and association: insights from the interfacial and thermodynamic properties of hydrocarbons. Proteins 11, 281-296.
58. Kraulis, P.J. (1991). MOLSCRIPT: a program to produce both detailed and schematic plots of protein structures. J. Appl. Cryst. 24, 946-950.